Please login to the form below

Not currently logged in
Email:
Password:

Lexicon

This page shows the latest Lexicon news and features for those working in and with pharma, biotech and healthcare.

FDA adcomm split on Sanofi’s type 1 diabetes drug

FDA adcomm split on Sanofi’s type 1 diabetes drug

According to Lexicon, sotagliflozin is also being tested in type 2 diabetes with phase 3 results due this later year. ... Sanofi licensed rights to sotagliflozin from Lexicon in 2015 for $300m upfront and up to $1.4bn in development, regulatory and sales

Latest news

More from news
Approximately 2 fully matching, plus 9 partially matching documents found.

Latest Intelligence

  • Communication is the key to unlocking the potential of immuno-oncology Communication is the key to unlocking the potential of immuno-oncology

    Marje Isabelle, Founder and CEO, Fertile Matters. This means working with others to define a new lexicon for cancer care; helping healthcare professionals stay on top of the deluge of new

  • Six degrees of participation Six degrees of participation

    Similarly, social listening is a great way of understanding the patient lexicon.

  • Asthma: beyond the blue and the brown Asthma: beyond the blue and the brown

    Indeed, it challenges the validity of the term ‘asthma’ in the modern day medical lexicon at all.

  • Deal Watch November 2016 Deal Watch November 2016

    Strategic alliance, options. 122.7 per. BMS/ Lexicon Pharmaceuticals. BMS-986176 for neutopathic pain (pc) plus other small molecules that act on same target.

  • Deal Watch November 2015 Deal Watch November 2015

    Under the agreement Lexicon receives an upfront payment of $300m with a further $1.4bn in development, regulatory and sales milestones. ... Lexicon will continue to lead the development programme and has retained commercial rights to type 1 diabetes in

More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest appointments

  • Weekly comms appointments Weekly comms appointments

    In this newly created position, Pyati will develop a science-driven strategy, implement situational assessments and workshops and develop scientific platforms and lexicons.

  • Linda Law joins Advicenne as US VP, clinical development and med affairs Linda Law joins Advicenne as US VP, clinical development and med affairs

    Law’s career has seen her serve in various positions for pharmaceutical companies including Procter &Gamble, Lexicon Pharmaceuticals and she has consulted on evaluation and development projects with Takeda, Confluence and

  • Onconova appoints Ajay Bansal as chief financial officer Onconova appoints Ajay Bansal as chief financial officer

    Bansal (pictured) served as chief financial officer at Complete Genomics since May 2010, having previously held the role of chief financial officer and executive VP of business development at Lexicon Therapeutics. ... In addition to his prior roles at

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Top Pharma News

TopPharmaNews.com is a global pharma magazine dedicated to delivering fresh news to society. The team at the TopPharmaNews.com cater non-biased,...

Latest intelligence

NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...

Infographics